Hot on the heels of our expansion into mental health-related and health-related Facebook apps, the health team is now leading the way in delivering practically up-to-the-minute medication information for consumers and health professionals, straight from the US Food and Drug Administration.
Eagle-eyed readers might have noticed that just a couple of weeks ago, we replaced our aging mental health medications section with a new and greatly expanded collection of information on over 100 drugs commonly used in several areas of mental health:
- Mood Stabilizers and Anticonvulsants
- Painkillers and Muscle Relaxants
(We didn’t erase the existing section, just moved it over to our supplementary reference library at CR Extras.)
Where did all that new information come from? It came straight from the horse’s mouth — directly from the respective medication manufacturers’ submissions to the US Food and Drug Administration. This means that the new information is as authoritative as you can get: this is the real deal, straight from the folks whose legal responsibility it is to inform and disclose what you need to know about medications. This is the type of information, submitted under the FDA’s Structured Product Labeling standard, which doctors use to prescribe, which informed consumers use to further educate themselves about their own treatment — and which, like it or not, lawyers use to litigate. (It also means that the information now has something of a US-centric skew, whereas our previous information was a mix of FDA information and highlights culled from the British National Formulary.)
The web is full of medication monographs, sometimes provided without citation or other indication of authorship, and often accompanied by a timestamp reflecting not when it was actually written but rather when it was last reviewed by an editor who may or may not have been any more medically qualified than your local newspaper delivery boy. The fact is that even most individual physicians are not well placed to undertake the type of extensive review and assessment of the latest medication information that is the bread and butter of the FDA’s work; certainly neither psychologists nor counsellors would call themselves well positioned to do so either.
So, we’ve decided to move entirely away from the “one man and his dog” style of medication overview and toward this type of authoritative, timely, in-depth material instead.
(Update: our medication information is now housed at some of our sister sites, rather than here at CounsellingResource.com.)
All clinical material on this site is peer reviewed by one or more clinical psychologists or other qualified mental health professionals. This specific article was originally published by Dr Greg Mulhauser, Managing Editor on .on and was last reviewed or updated by